Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Another Valuation

<< Previous

Bullboard Posts

Next >>

Comment by xodcodeon Jun 07, 2022 10:26am

171 Views

Post# 34736808

RE:RE:RE:Another Valuation

Again, difficult to believe that a 200 million share company trades so few share on any given day. Suggests to me that longs aren't selling at these levels and new buyers are taking their time in obtaining shares.

With any new positive Vaccine, Cancer treatment or Partnership news, TLT, with the aforementioned low daily volume, is poised to skyrocked into double digits imo!

<< Previous

Bullboard Posts

Next >>

Day trading vs. swing trading strategies for small-cap stocks